All stock lists
Buda Juice, Inc. (New York Stock Exchange Arca:BUDA)
US · Delayed Price · Currency is USD
Consumer Defensive · Beverages - Non-Alcoholic
$5.83-$1.00 (-14.64%)
Market cap
$73.3M
Insider Score
Health Score
Listed since
Jan 8, 2026
Website
Insider Score
––Not scored
BUDA Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From BUDA’s reported statements · Q3 2026 (trailing 12 months)
Profitability17 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $16.1M
- Net income
- $2.4M
- Net margin
- 14.9%
Leverage20 / 20
Little or no net debt.
- Total debt
- $682K
- Cash
- $19.3M
- Net debt / EBITDA
- -6.19x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $22.6M
- Current liabilities
- $1.5M
- Current ratio
- 15.52
Cash generation19 / 20
The business funds itself from operations.
- Operating cash flow
- $2.1M
- Free cash flow
- $2.2M
- FCF margin
- 13.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 12.6M
- Share growth (1y)
- -0.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BUDA Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $5.21 M | $4.51 M | $3.51 M | $2.90 M | $3.17 M | $3.57 M |
| Revenue Growth (YoY) | 64.41 % | 26.38 % | 17.72 % | 4.44 % | 9.06 % | 27.44 % |
| Cost of Revenue | $3.08 M | $2.86 M | $2.18 M | $1.70 M | $1.82 M | $1.90 M |
| Gross Profit | $2.12 M | $1.65 M | $1.33 M | $1.20 M | $1.35 M | $1.67 M |
| SG&A Expense | $925.00 K | $1.21 M | $736.00 K | $567.00 K | $486.00 K | $378.00 K |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $1.13 M | $1.21 M | $736.00 K | $535.00 K | $486.00 K | $523.00 K |
| Operating Income | $996.00 K | $444.00 K | $593.00 K | $660.00 K | $860.00 K | $1.14 M |
| Pretax Income | $1.14 M | $599.00 K | $747.00 K | $675.00 K | $881.00 K | $1.18 M |
| Tax Provision | $274.00 K | $129.00 K | $359.00 K | $0.00 | $0.00 | $9.00 K |
| Net Income | $866.00 K | $470.00 K | $388.00 K | $675.00 K | $881.00 K | $1.17 M |
| EPS (Basic) | $0.07 | $0.04 | $0.03 | $0.05 | $0.07 | $0.12 |
| EPS (Diluted) | $0.07 | $0.04 | $0.03 | $0.05 | $0.07 | $0.08 |
| Shares Outstanding | 12.57 M | 12.57 M | 12.57 M | 12.57 M | 12.67 M | 10.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.